Children's Oncology Group's 2023 blueprint for research: Surgery

Surgery plays a crucial role in the treatment of children with solid malignancies. A well‐conducted operation is often essential for cure. Collaboration with the primary care team is important for determining if and when surgery should be performed, and if performed, an operation must be done in acc...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric blood & cancer 2024-03, Vol.71 (3), p.e30766-n/a
Main Authors: Gow, Kenneth W., Lautz, Timothy B., Malek, Marcus M., Cost, Nicholas G., Newman, Erika A., Dasgupta, Roshni, Christison‐Lagay, Emily R., Tiao, Gregory M., Davidoff, Andrew M.
Format: Article
Language:English
Subjects:
Bone cancer
Child
Children
education
germ cell tumor
hepatoblastoma
Humans
imaging
Malignancy
Medical Oncology
Neoplasms - surgery
neuroblastoma
Oncology
osteosarcoma
Pediatrics
Primary care
quality assurance
Sarcoma
Surgery
synoptic operative notes
technology
Wilms tumor
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Surgery plays a crucial role in the treatment of children with solid malignancies. A well‐conducted operation is often essential for cure. Collaboration with the primary care team is important for determining if and when surgery should be performed, and if performed, an operation must be done in accordance with well‐established standards. The long‐term consequences of surgery also need to be considered. Indications and objectives for a procedure vary. Providing education and developing and analyzing new research protocols that include aims relevant to surgery are key objectives of the Surgery Discipline of the Children's Oncology Group. The critical evaluation of emerging technologies to ensure safe, effective procedures is another key objective. Through research, education, and advancing technologies, the role of the pediatric surgeon in the multidisciplinary care of children with solid malignancies will continue to evolve.
ISSN:1545-5009
1545-5017
1545-5017
DOI:10.1002/pbc.30766